Selected research
Industry Research
Veterinary Drugs Industry Research Report 2026
Market perspective
The global Veterinary Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Veterinary Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Veterinary Drugs market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Veterinary Drugs market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Veterinary Drugs include Zoetis Inc., Merck Animal Health, Bayer AG, Virbac SA, Vetoquinol SA, IDEXX Laboratories, Inc., Elanco, Covetrus, Inc. and Ceva Sante Animale S.A. and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Veterinary Drugs market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Veterinary Drugs.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Veterinary Drugs Market by Company
Zoetis Inc.
Merck Animal Health
Bayer AG
Virbac SA
Vetoquinol SA
IDEXX Laboratories, Inc.
Elanco
Covetrus, Inc.
Ceva Sante Animale S.A.
Boehringer Ingelheim Animal Health
Veterinary Drugs Segment by Type
Treatment Drugs
Vaccines
Others
Veterinary Drugs Segment by Application
Chickens
Cattle
Swine
Others
Veterinary Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Veterinary Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Treatment Drugs
- Vaccines
- Others
Applications
- Chickens
- Cattle
- Swine
- Others
Companies covered
- Zoetis Inc.
- Merck Animal Health
- Bayer AG
- Virbac SA
- Vetoquinol SA
- IDEXX Laboratories, Inc.
- Elanco
- Covetrus, Inc.
- Ceva Sante Animale S.A.
- Boehringer Ingelheim Animal Health
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Veterinary Drugs by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Treatment Drugs
- 2.2.3 Vaccines
- 2.2.4 Others
- 2.3 Veterinary Drugs by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Chickens
- 2.3.3 Cattle
- 2.3.4 Swine
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Veterinary Drugs Breakdown Data by Type
- 3.1 Global Veterinary Drugs Historic Market Size by Type (2021-2026)
- 3.2 Global Veterinary Drugs Forecasted Market Size by Type (2027-2032)
4 Veterinary Drugs Breakdown Data by Application
- 4.1 Global Veterinary Drugs Historic Market Size by Application (2021-2026)
- 4.2 Global Veterinary Drugs Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Veterinary Drugs Market Perspective (2021-2032)
- 5.2 Global Veterinary Drugs Growth Trends by Region
- 5.2.1 Global Veterinary Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Veterinary Drugs Historic Market Size by Region (2021-2026)
- 5.2.3 Veterinary Drugs Forecasted Market Size by Region (2027-2032)
- 5.3 Veterinary Drugs Market Dynamics
- 5.3.1 Veterinary Drugs Industry Trends
- 5.3.2 Veterinary Drugs Market Drivers
- 5.3.3 Veterinary Drugs Market Challenges
- 5.3.4 Veterinary Drugs Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Veterinary Drugs Players by Revenue
- 6.1.1 Global Top Veterinary Drugs Players by Revenue (2021-2026)
- 6.1.2 Global Veterinary Drugs Revenue Market Share by Players (2021-2026)
- 6.2 Global Veterinary Drugs Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Veterinary Drugs Head Office and Area Served
- 6.4 Global Veterinary Drugs Players, Product Type & Application
- 6.5 Global Veterinary Drugs Manufacturers Established Date
- 6.6 Global Veterinary Drugs Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Veterinary Drugs Market Size (2021-2032)
- 7.2 North America Veterinary Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Veterinary Drugs Market Size by Country (2021-2026)
- 7.4 North America Veterinary Drugs Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Veterinary Drugs Market Size (2021-2032)
- 8.2 Europe Veterinary Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Veterinary Drugs Market Size by Country (2021-2026)
- 8.4 Europe Veterinary Drugs Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Veterinary Drugs Market Size (2021-2032)
- 9.2 Asia-Pacific Veterinary Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Veterinary Drugs Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Veterinary Drugs Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Veterinary Drugs Market Size (2021-2032)
- 10.2 South America Veterinary Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Veterinary Drugs Market Size by Country (2021-2026)
- 10.4 South America Veterinary Drugs Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Veterinary Drugs Market Size (2021-2032)
- 11.2 Middle East & Africa Veterinary Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Veterinary Drugs Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Veterinary Drugs Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Zoetis Inc.
- 12.1.1 Zoetis Inc. Company Information
- 12.1.2 Zoetis Inc. Business Overview
- 12.1.3 Zoetis Inc. Revenue in Veterinary Drugs Business (2021-2026)
- 12.1.4 Zoetis Inc. Veterinary Drugs Product Portfolio
- 12.1.5 Zoetis Inc. Recent Developments
- 12.2 Merck Animal Health
- 12.2.1 Merck Animal Health Company Information
- 12.2.2 Merck Animal Health Business Overview
- 12.2.3 Merck Animal Health Revenue in Veterinary Drugs Business (2021-2026)
- 12.2.4 Merck Animal Health Veterinary Drugs Product Portfolio
- 12.2.5 Merck Animal Health Recent Developments
- 12.3 Bayer AG
- 12.3.1 Bayer AG Company Information
- 12.3.2 Bayer AG Business Overview
- 12.3.3 Bayer AG Revenue in Veterinary Drugs Business (2021-2026)
- 12.3.4 Bayer AG Veterinary Drugs Product Portfolio
- 12.3.5 Bayer AG Recent Developments
- 12.4 Virbac SA
- 12.4.1 Virbac SA Company Information
- 12.4.2 Virbac SA Business Overview
- 12.4.3 Virbac SA Revenue in Veterinary Drugs Business (2021-2026)
- 12.4.4 Virbac SA Veterinary Drugs Product Portfolio
- 12.4.5 Virbac SA Recent Developments
- 12.5 Vetoquinol SA
- 12.5.1 Vetoquinol SA Company Information
- 12.5.2 Vetoquinol SA Business Overview
- 12.5.3 Vetoquinol SA Revenue in Veterinary Drugs Business (2021-2026)
- 12.5.4 Vetoquinol SA Veterinary Drugs Product Portfolio
- 12.5.5 Vetoquinol SA Recent Developments
- 12.6 IDEXX Laboratories, Inc.
- 12.6.1 IDEXX Laboratories, Inc. Company Information
- 12.6.2 IDEXX Laboratories, Inc. Business Overview
- 12.6.3 IDEXX Laboratories, Inc. Revenue in Veterinary Drugs Business (2021-2026)
- 12.6.4 IDEXX Laboratories, Inc. Veterinary Drugs Product Portfolio
- 12.6.5 IDEXX Laboratories, Inc. Recent Developments
- 12.7 Elanco
- 12.7.1 Elanco Company Information
- 12.7.2 Elanco Business Overview
- 12.7.3 Elanco Revenue in Veterinary Drugs Business (2021-2026)
- 12.7.4 Elanco Veterinary Drugs Product Portfolio
- 12.7.5 Elanco Recent Developments
- 12.8 Covetrus, Inc.
- 12.8.1 Covetrus, Inc. Company Information
- 12.8.2 Covetrus, Inc. Business Overview
- 12.8.3 Covetrus, Inc. Revenue in Veterinary Drugs Business (2021-2026)
- 12.8.4 Covetrus, Inc. Veterinary Drugs Product Portfolio
- 12.8.5 Covetrus, Inc. Recent Developments
- 12.9 Ceva Sante Animale S.A.
- 12.9.1 Ceva Sante Animale S.A. Company Information
- 12.9.2 Ceva Sante Animale S.A. Business Overview
- 12.9.3 Ceva Sante Animale S.A. Revenue in Veterinary Drugs Business (2021-2026)
- 12.9.4 Ceva Sante Animale S.A. Veterinary Drugs Product Portfolio
- 12.9.5 Ceva Sante Animale S.A. Recent Developments
- 12.10 Boehringer Ingelheim Animal Health
- 12.10.1 Boehringer Ingelheim Animal Health Company Information
- 12.10.2 Boehringer Ingelheim Animal Health Business Overview
- 12.10.3 Boehringer Ingelheim Animal Health Revenue in Veterinary Drugs Business (2021-2026)
- 12.10.4 Boehringer Ingelheim Animal Health Veterinary Drugs Product Portfolio
- 12.10.5 Boehringer Ingelheim Animal Health Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst